Literature DB >> 19063820

Role of leukotrienes in exercise-induced bronchoconstriction.

Teal S Hallstrand1, William R Henderson.   

Abstract

Exercise-induced bronchoconstriction (EIB) refers to acute airflow obstruction that is triggered by a period of physical exertion. EIB occurs mainly in individuals with other features of asthma but is especially prominent in a subset of asthmatics with pronounced indirect airway hyperresponsiveness. Leukotrienes (LTs) play a critical role in the pathophysiology of EIB. Asthmatics who are susceptible to EIB have increased levels of cysteinyl LTs (cysLTs [ie, LTs C4, D4, and E4]) in induced sputum and exhaled breath condensate. Exercise challenge in individuals susceptible to this disorder initiates the sustained increase in cysLTs in the airways and an increase in the ratio of cysLTs to prostaglandin E(2). The effects of cysLTs leading to secreted mucin release and smooth muscle constriction may be mediated in part through activation of sensory nerves. Therapies that block cysLT production or the cysLT(1) receptor effectively reduce the severity of EIB.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19063820     DOI: 10.1007/s11882-009-0003-8

Source DB:  PubMed          Journal:  Curr Allergy Asthma Rep        ISSN: 1529-7322            Impact factor:   4.806


  49 in total

1.  Role of leukotrienes in exercise-induced asthma. Inhibitory effect of ICI 204219, a potent leukotriene D4 receptor antagonist.

Authors:  J P Finnerty; R Wood-Baker; H Thomson; S T Holgate
Journal:  Am Rev Respir Dis       Date:  1992-04

Review 2.  Regulation of airway surface liquid volume and mucus transport by active ion transport.

Authors:  Robert Tarran
Journal:  Proc Am Thorac Soc       Date:  2004

3.  Onset and duration of protection against exercise-induced bronchoconstriction by a single oral dose of montelukast.

Authors:  David S Pearlman; Janet van Adelsberg; George Philip; Stephen A Tilles; William Busse; Leslie Hendeles; Thomas Loeys; S Balachandra Dass; Theodore F Reiss
Journal:  Ann Allergy Asthma Immunol       Date:  2006-07       Impact factor: 6.347

4.  Bronchoprotective effects of single doses of salmeterol combined with montelukast in thermally induced bronchospasm.

Authors:  Albert Coreno; Mary Skowronski; Erin West; Amr El-Ekiaby; E R McFadden
Journal:  Chest       Date:  2005-05       Impact factor: 9.410

5.  Exercise-induced bronchoconstriction in children: montelukast attenuates the immediate-phase and late-phase responses.

Authors:  Raul E Melo; Dirceu Solé; Charles K Naspitz
Journal:  J Allergy Clin Immunol       Date:  2003-02       Impact factor: 10.793

6.  A comparison of the effects of oral montelukast and inhaled salmeterol on response to rescue bronchodilation after challenge.

Authors:  William Storms; Paul Chervinsky; Asma F Ghannam; Steven Bird; Carolyn M Hustad; Jonathan M Edelman
Journal:  Respir Med       Date:  2004-11       Impact factor: 3.415

7.  Release of prostaglandin D2 and leukotriene C4 in response to hyperosmolar stimulation of mast cells.

Authors:  M Gulliksson; L Palmberg; G Nilsson; S Ahlstedt; M Kumlin
Journal:  Allergy       Date:  2006-12       Impact factor: 13.146

8.  Effect of different antiasthmatic treatments on exercise-induced bronchoconstriction in children with asthma.

Authors:  Iwona Stelmach; Tomasz Grzelewski; Pawel Majak; Joanna Jerzynska; Wlodzimierz Stelmach; Piotr Kuna
Journal:  J Allergy Clin Immunol       Date:  2007-11-05       Impact factor: 10.793

Review 9.  What's all the FLAP about?: 5-lipoxygenase-activating protein inhibitors for inflammatory diseases.

Authors:  Jilly F Evans; Andrew D Ferguson; Ralph T Mosley; John H Hutchinson
Journal:  Trends Pharmacol Sci       Date:  2008-01-09       Impact factor: 14.819

10.  Importance of group X-secreted phospholipase A2 in allergen-induced airway inflammation and remodeling in a mouse asthma model.

Authors:  William R Henderson; Emil Y Chi; James G Bollinger; Ying-tzang Tien; Xin Ye; Luca Castelli; Yuri P Rubtsov; Alan G Singer; Gertrude K S Chiang; Timo Nevalainen; Alexander Y Rudensky; Michael H Gelb
Journal:  J Exp Med       Date:  2007-04-02       Impact factor: 14.307

View more
  17 in total

Review 1.  An update on exercise-induced bronchoconstriction with and without asthma.

Authors:  Chris Randolph
Journal:  Curr Allergy Asthma Rep       Date:  2009-11       Impact factor: 4.806

Review 2.  New insights into pathogenesis of exercise-induced bronchoconstriction.

Authors:  Teal S Hallstrand
Journal:  Curr Opin Allergy Clin Immunol       Date:  2012-02

Review 3.  Function of secreted phospholipase A2 group-X in asthma and allergic disease.

Authors:  James D Nolin; Ryan C Murphy; Michael H Gelb; William A Altemeier; William R Henderson; Teal S Hallstrand
Journal:  Biochim Biophys Acta Mol Cell Biol Lipids       Date:  2018-12-05       Impact factor: 4.698

4.  Fatty acids induce leukotriene C4 synthesis in macrophages in a fatty acid binding protein-dependent manner.

Authors:  Eric K Long; Kristina Hellberg; Rocio Foncea; Ann V Hertzel; Jill Suttles; David A Bernlohr
Journal:  Biochim Biophys Acta       Date:  2013-04-12

5.  Exercise-induced wheeze, urgent medical visits, and neighborhood asthma prevalence.

Authors:  Timothy R Mainardi; Robert B Mellins; Rachel L Miller; Luis M Acosta; Alexandra Cornell; Lori Hoepner; James W Quinn; Beizhan Yan; Steven N Chillrud; Omar E Olmedo; Frederica P Perera; Inge F Goldstein; Andrew G Rundle; Judith S Jacobson; Matthew S Perzanowski
Journal:  Pediatrics       Date:  2012-12-17       Impact factor: 7.124

6.  Regulation and function of epithelial secreted phospholipase A2 group X in asthma.

Authors:  Teal S Hallstrand; Ying Lai; William A Altemeier; Cara L Appel; Brian Johnson; Charles W Frevert; Kelly L Hudkins; James G Bollinger; Prescott G Woodruff; Dallas M Hyde; William R Henderson; Michael H Gelb
Journal:  Am J Respir Crit Care Med       Date:  2013-07-01       Impact factor: 21.405

7.  Randomized controlled trial of fish oil and montelukast and their combination on airway inflammation and hyperpnea-induced bronchoconstriction.

Authors:  Sandra Tecklenburg-Lund; Timothy D Mickleborough; Louise A Turner; Alyce D Fly; Joel M Stager; Gregory S Montgomery
Journal:  PLoS One       Date:  2010-10-18       Impact factor: 3.240

8.  Distinctive bronchial inflammation status in athletes: basophils, a new player.

Authors:  Beatriz Sastre; Mar Fernández-Nieto; María Jesús Rodríguez-Nieto; Erica Aguado; Joaquín Sastre; Victoria del Pozo
Journal:  Eur J Appl Physiol       Date:  2012-08-24       Impact factor: 3.078

Review 9.  Which biomarkers are effective for identifying Th2-driven inflammation in asthma?

Authors:  Zuzana Diamant; Ellen Tufvesson; Leif Bjermer
Journal:  Curr Allergy Asthma Rep       Date:  2013-10       Impact factor: 4.806

Review 10.  An update on the role of leukotrienes in asthma.

Authors:  Teal S Hallstrand; William R Henderson
Journal:  Curr Opin Allergy Clin Immunol       Date:  2010-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.